• The document contains the transcript of Rajshree Polypack Limited's Q2 and H1 FY27 Earnings Conference Call held on November 04, 2026, hosted by Churchgate Advisory Private Limited.
  • Management participants included Mr. Ramswaroop Thard (Chairman and Managing Director) and Mr. Sunil Sharma (Chief Financial Officer).
  • The purpose was to discuss the Unaudited Financial Results (Consolidated and Standalone) for the quarter and half year ended September 30, 2026.
  • Key financial highlights from the call:
  • Standalone Q2 FY27 revenue: INR 102.90 crores (up 19% YoY from INR 86.43 crores)
  • Q2 operating EBITDA: INR 13.05 crores with margin of 12.69% (vs 12.66% YoY)
  • Q2 profit after tax: INR 5.02 crores
  • H1 FY27 revenue: INR 205.81 crores (up 21.82% YoY)
  • H1 operating EBITDA: INR 27.47 crores (up 30.50% YoY) with margin of 13.35% (improved 89 bps)
  • H1 profit after tax: INR 12.27 crores (vs INR 8.71 crores YoY)
  • Export revenue: Q2 INR 14.46 crores, H1 INR 26.18 crores
  • Cash flow from operations H1: INR 17.72 crores
  • Debt-to-equity ratio: 0.53 times (improved from 0.57 times at FY26 end)
  • Olive Ecopak (subsidiary) performance:
  • Q2 revenue: INR 21.15 crores (vs INR 17.22 crores in Q1)
  • Q2 EBITDA: INR 6.72 crores with margin of 31.82% (vs 26.79% in Q1)
  • H1 revenue: INR 38.36 crores
  • H1 EBITDA: INR 11.33 crores with margin of 29.53%
  • Business was PBT positive before flood-related exceptional losses
  • Operational updates:
  • Injection moulding capacity now at 5,800 metric tons per annum (vs 1,000 tons in FY23)
  • 1.9 MW renewable energy project commissioned in October 2026, expected to meet 30% of energy requirements
  • Phase 1 capex at Odisha currently deferred
  • Guidance provided:
  • FY27 revenue guidance: INR 390-400 crores
  • FY27 EBITDA margin target: 15% (±0.5%) for plastics business
  • Olive Ecopak FY27 revenue guidance: INR 95 crores (±5 crores)
  • FY28 revenue potential: INR 450-460 crores at full capacity utilization
  • Additional revenue potential: INR 40-50 crores from injection moulding, INR 30-40 crores from thermoforming
  • Current capacity utilization: 75-80% across different processes

Additional Notes Section

  • The transcript was attached to the regulatory filing and is also available on the company website.
  • The document contains detailed financial data and management commentary from the earnings call.
  • No compliance language regarding unpublished price sensitive information was included in this transcript.